1.
Sulzer,
D.
and L.
Zecca,
Intraneuronal dopamine-quinone synthesis: a review. Neurotox Res,
2000.
1(3): p.
181-95.
2.
Zecca,
L.,
et al.,
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease. J Neurochem,
2008.
106(4): p.
1866-75.
3.
Ito,
S.,
Encapsulation of a reactive core in neuromelanin. Proceedings of the National Academy of Sciences of the United States of America,
2006.
103(40): p.
14647-14648.
4.
Zucca,
F.A.,
et al.,
Neuromelanin of the human substantia nigra: an update. Neurotox Res,
2014.
25(1): p.
13-23.
5.
Enochs,
W.S.,
M.J.
Nilges,
and H.M.
Swartz,
Purified Human Neuromelanin,
Synthetic Dopamine Melanin as a Potential Model Pigment,
and the Normal Human Substantia Nigra: Characterization by Electron Paramagnetic Resonance Spectroscopy. Journal of Neurochemistry,
1993.
61(1): p.
68-79.
6.
Cowen,
D.,
The melanoneurons of the human cerebellum (nucleus pigmentosus cerebellaris) and homologues in the monkey. J Neuropathol Exp Neurol,
1986.
45(3): p.
205-21.
7.
Halliday,
G.M.,
et al.,
Evidence for specific phases in the development of human neuromelanin. Journal of Neural Transmission,
2006.
113(6): p.
721-728.
8. Fearnley,
J.M.
and A.J.
Lees,
Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain,
1991.
114 ( Pt 5): p.
2283-301.
9.
Ma,
et al.,
Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing. Neuropathology and Applied Neurobiology,
1999.
25(5): p.
394-399.
10.
McGeer,
P.L.,
E.G.
McGeer,
and J.S.
Suzuki,
Aging and extrapyramidal function. Arch Neurol,
1977.
34(1): p.
33-5.
11.
Zecca,
L.,
et al.,
Iron,
neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem,
2001.
76(6): p.
1766-73.
12.
Fedorow,
H.,
et al.,
Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease. Prog Neurobiol,
2005.
75(2): p.
109-24.
13.
Shibata,
E.,
et al.,
Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. Magn Reson Med Sci,
2006.
5(4): p.
197-200.
14.
Watanabe,
Y.,
et al.,
Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia. PLoS One,
2014.
9(8): p.
e104619.